Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Avainsanat:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideAbstrakti
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Tiedostolataukset
Julkaistu
2021-02-05
Numero
Osasto
Review Article
Lisenssi
Copyright (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema
Tämä työ on lisensoitu Creative Commons Nimeä-EiKaupallinen 4.0 Kansainvälinen Julkinen -lisenssillä.
Viittaaminen
Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089
